Relationship between estrogen and temporomandibular disorders: a review of literature

Authors

  • Laura Gomes Berrutti Universidade Luterana do Brasil
  • Gabriela Moraes Machado Universidade Luterana do Brasil
  • Flávio Renato Reis de Moura Universidade Luterana do Brasil
  • Myrian Camara Brew Universidade Luterana do Brasil
  • Caren Serra Bavaresco Universidade Luterana do Brasil

DOI:

https://doi.org/10.5335/rfo.v25i2.10371

Keywords:

temporomandibular dysfunction; orofacial pain; estrogen

Abstract

Objective: to carry out an integrative review of the literature in order to outline the role of estrogen in temporomandibular disorders. Methodology: the study searched studies in the digital platforms PubMed, SciELO and Google Acadêmico, from September 2018 to May 2019, without filters to determine the time period, excluding those works in which it was not possible to identify relation with the theme. Results: among the analysis of the studies found, the relationship between estrogen and the prevalence of temporomandibular disorders in women was observed. Estrogen acts centrally and peripherally in the central nervous system, influencing the processing of the pro and antinoceptive receptors of the temporomandibular joint. Final considerations: estrogenic modulation of pain is a complex mechanism. Several studies associate the estrogen hormone with temporomandibular disorders. Although there is no consensus among authors of the exact role of this hormone, there is proven evidence that women have a susceptibility to pain in general, with prevalence both in frequency and intensity.

Downloads

Download data is not yet available.

References

1. Okeson JP. Dor orofacial guia de avaliação, diagnóstico e tratamento. São Paulo: Quintessense; 1998.
2. Leeuw R. Dor orofacial: guia de avaliação, diagnóstico e tratamento. 4. ed. Academia Americana de Dor Orofacial; Quintessense; 2009.
3. IASP. Classification of chronic pain: descriptors of chronic pain syndromes and definitions of pain terms. 2. ed. Seattle: IASP Press; 1994.
4. Oliveira AS, Bermudez CC, Souza RA, Souza CMF, Dias EM, Castro CES, et al. Impacto da dor na vida de portadores de Disfunção Temporomandibular. J Appl Oral Sci 2003; 11(2):138-4.
5. Pereira KNF, Andrade LLS, Costa MLG, Portal TF. Sinais e Sintomas de pacientes com Disfunção Temporomandibular. Rev CEFA 2005; 7(2):221-8.
6. Neville BW. Patologia oral e maxilofacial. 3. ed. Elsevier; 2009.
7. Scully C. Medicina oral e maxilofacial: bases do diagnóstico e tratamento. 2. ed. Rio de Janeiro: Elsevier; 2008. 8. Tanaka EE, Arita ES, Shibayama B. Occlusal stabilization appliance: evaluation of its efficacy in the treatment of temporomandibular disorders. J Appl Oral Sci 2004; 12(3):23843.
9. Alcantara GR. As disfunções da ATM relacionas à cervicalgia. Monografia de Conclusão de Curso apresentada ao Curso de Fisioterapia da Universidade Veiga de Almeida, Rio de Janeiro; 2008.
10. Favero EK. Disfunções da articulação temporomandibular: uma visão etiológica e terapêutica multidisciplinar. Monografia do Centro de Especialização em Fonoaudiologia Clínica (CEFAC); 1999.
11. Naikmasur V. Soft occlusal splint therapy in the management of myofascial pain dysfunction syndrome: a follow-up study. Indian J Dent Res 2008; 19(3):196-203.
12. Cauás M. Incidências de hábitos parafuncionais e posturais em pacientes portadores de Disfunção da Articulação Craniomandibular. Revista de Cirurgia e Traumatologia Buco-Maxilo-Facial 2004; 4(2):121-9.
13. Shaefer JR, Khawaja SN, Bavia PF. Sex, gender, and orofacial pain. Dental Clinics of North America 2018; 62(4):665-82.
14. Unruh AM. Gender variations in clinical pain experience. Pain 1996; 65(2):123-67.
15. Cairns BE. Pathophysiology of TMD pain: basic mechanisms and their implications for pharmacotherapy. J Oral Rehabil 2010; 37(6):391-410.
16. Bereiter DA, Okamoto K. Neurobiology of estrogen status in deep craniofacial pain. Int Rev Neurobiol 2011; 97:251-84.
17. Le Resche L, Saunders K, Von Korff MR, Barlow W, Dworkin SF. Use of exogenous hormones and risk of temporomandibular disorder pain. Pain 1997; 69(1-2):153-60.
18. Bernardi MT, Bussadori SK, Fernandes KPS, Biasotto-Gonzalez DA. Correlação entre estresse e cefaléia tensional. Fisioterapia em Movimento 2008; 21(1):87-93.
19. Craft RM. Modulation of pain by estrogens. Pain 2007; 132(1):3-12.
20. Wiesenfeld-Hallin Z. Sex differences in pain perception. Gender Med 2005; 2:137-45.
21. Schmid-Schwap M, Bristela M, Kundi M, Piehslinger E. Sexspecific differences in patients with temporomandibular disorders. Journal of Orofacial Pain 2011; 27(1):42-50.
22. Winocur E, Littner D, Adams I, Gavish A. Oral habits and their association with signs and symptoms of temporomandibular disorders in adolescents: a gender comparison. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102(4):482-7.
23. Alfaya TA, Zukowska HR, Uemoto L, de Oliveira SSI, Martinez OER, Garcia MAC, et al. Alterações psicossomáticas e hábitos parafuncionais em indivíduos com disfunção temporomandibular. Saúde e Pesquisa 2013; 6(2):482-7.
24. Roda RP, Bagan JV, Fernández JMD, Bazán SH, Soriano YJ. Review of temporomandibular joint pathology. Part I: classification, epidemiology and risk factors. Med Oral Patol Oral Cir Bucal 2007; 1;12(4):292-8.
25. Zubieta JK, Smith YR, Bueller JA. μ-opioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci 2002; 22:5100-7.
26. Smith YR, Stohler CS, Nichols TE, Bueller JA, Koeppe RA, Zubieta JK. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotrans-mission in women. J Neurosci 2006; 26:5777-85.
27. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States: Relation to age, income, race, and other sociodemographic factors. JAMA 1992; 267:64-9.
28. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache 2001; 41:646-57.
29. Aloisi AM, Bachiocco V, Costantino A, Stefani R, Ceccarelli I, Bertaccini A, et al. Cross-sex hormone administration changes pain in transsexual women and men. Pain 2007; 132(1):60-67.
30. Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007; 28:521-74.
31. Casatti CA, Frigo L, Bauer JA. Origin of Sensory and Autonomic Innervation of the Rat Temporomandibular Joint: A Retrograde Axonal Tracing Study with the Fluorescent Dye Fast Blue. Journal of Dental Research 1999; 78(3):776-83.
32. Uddman R, Grunditz T, Kato J, Sundler F. Distribution and origin of nerve fibers in the rat temporomandibular joint capsule. Anatomy and Embryology 1998; 197:273-82.
33. Kido MA, Kiyoshima T, Ibuki T, Shimizu S, Kondo T, Terada Y, et al. A Topographical and Ultrastructural Study of Sensory Trigeminal Nerve Endings in the Rat Temporomandibular Joint as Demonstrated by Anterograde Transport of Wheat Germ Agglutinin-Horseradish Peroxidase (WGAHRP). Journal of Dental Research 1995; 74(7):1353-9.
34. Sessle BJ. The Neural Basis of Temporomandibular Joint and Masticatory Muscle Pain J Orofacial Pain 1999; 13(4):238-45.
35. Cairns BE, Sim Y, Bereiter DA, Sessle BJ, Hu JW. Influence of sex on reflex jaw muscle activity evoked from the rat temporomandibular joint. Brain Research 2002; 957(2):338-44.
36. Cairns BE, Sessle BJ, Hu JW. Characteristics of glutamateevoked temporomandibular joint afferent activity in the rat. Journal of Neurophysiology 2001; 85:2446-54.
37. Bereiter DA. Sex differences in bran stem neural activation after injury to the TMJ region. Cells Tissues Organs 2001; 169:226-37.

Published

2021-06-02

Issue

Section

Revisão de Literatura

How to Cite

Relationship between estrogen and temporomandibular disorders: a review of literature. (2021). Revista Da Faculdade De Odontologia - UPF, 25(2), 284-290. https://doi.org/10.5335/rfo.v25i2.10371